VIA Bloomberg-July 2010 SEROQUEL NEWS
AstraZeneca to Face 2012 Trial in Arkansas Over Sales of Anti-Psychotic
"AstraZeneca Plc (AZN) must face a trial over claims by Arkansas that the drugmaker hid health risks of its anti-psychotic drug Seroquel when selling it to residents covered by the state’s Medicaid program, a judge ruled.
London-based AstraZeneca, which agreed in March to pay $68.5 million to resolve claims that it deceptively marketed Seroquel in a number of states, will face a September 2012 trial of a lawsuit filed by Arkansas Attorney General Dustin McDaniel over sales of the drug, Circuit Judge Chris Piazza in Little Rock ruled today.
Arkansas officials, who opted out of the March Seroquel settlement, contend AstraZeneca defrauded the state’s Medicaid program by failing to properly outline the anti-psychotic medicine’s risks in its warning label. The state seeks a $5,000 penalty for each Seroquel prescription written in Arkansas over an 11-year period starting in 1997, according to Fletcher Trammell, one of the state’s lawyers."
Continue reading Bloomberg article here
Subscribe to:
Post Comments (Atom)
Posts
1 comments:
Oh how I wish that I could sue GSK because Paxil made me bat sh*t crazy, but alas - I cannot, but I can keep telling my story.
Post a Comment